Cargando…
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935849/ https://www.ncbi.nlm.nih.gov/pubmed/36797234 http://dx.doi.org/10.1038/s41408-023-00800-2 |
| _version_ | 1784890102726524928 |
|---|---|
| author | Ilyas, Rimal McCullough, Kristen Badar, Talha Patnaik, Mrinal M. Alkhateeb, Hassan Mangaonkar, Abhishek Pardanani, Animesh Tefferi, Ayalew Gangat, Naseema |
| author_facet | Ilyas, Rimal McCullough, Kristen Badar, Talha Patnaik, Mrinal M. Alkhateeb, Hassan Mangaonkar, Abhishek Pardanani, Animesh Tefferi, Ayalew Gangat, Naseema |
| author_sort | Ilyas, Rimal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9935849 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99358492023-02-18 CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases Ilyas, Rimal McCullough, Kristen Badar, Talha Patnaik, Mrinal M. Alkhateeb, Hassan Mangaonkar, Abhishek Pardanani, Animesh Tefferi, Ayalew Gangat, Naseema Blood Cancer J Correspondence Nature Publishing Group UK 2023-02-17 /pmc/articles/PMC9935849/ /pubmed/36797234 http://dx.doi.org/10.1038/s41408-023-00800-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Ilyas, Rimal McCullough, Kristen Badar, Talha Patnaik, Mrinal M. Alkhateeb, Hassan Mangaonkar, Abhishek Pardanani, Animesh Tefferi, Ayalew Gangat, Naseema CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases |
| title | CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases |
| title_full | CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases |
| title_fullStr | CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases |
| title_full_unstemmed | CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases |
| title_short | CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases |
| title_sort | cpx-351 (vyxeos™) treatment in blast-phase myeloproliferative neoplasm (mpn-bp): real-world experience in 12 consecutive cases |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935849/ https://www.ncbi.nlm.nih.gov/pubmed/36797234 http://dx.doi.org/10.1038/s41408-023-00800-2 |
| work_keys_str_mv | AT ilyasrimal cpx351vyxeostreatmentinblastphasemyeloproliferativeneoplasmmpnbprealworldexperiencein12consecutivecases AT mcculloughkristen cpx351vyxeostreatmentinblastphasemyeloproliferativeneoplasmmpnbprealworldexperiencein12consecutivecases AT badartalha cpx351vyxeostreatmentinblastphasemyeloproliferativeneoplasmmpnbprealworldexperiencein12consecutivecases AT patnaikmrinalm cpx351vyxeostreatmentinblastphasemyeloproliferativeneoplasmmpnbprealworldexperiencein12consecutivecases AT alkhateebhassan cpx351vyxeostreatmentinblastphasemyeloproliferativeneoplasmmpnbprealworldexperiencein12consecutivecases AT mangaonkarabhishek cpx351vyxeostreatmentinblastphasemyeloproliferativeneoplasmmpnbprealworldexperiencein12consecutivecases AT pardananianimesh cpx351vyxeostreatmentinblastphasemyeloproliferativeneoplasmmpnbprealworldexperiencein12consecutivecases AT tefferiayalew cpx351vyxeostreatmentinblastphasemyeloproliferativeneoplasmmpnbprealworldexperiencein12consecutivecases AT gangatnaseema cpx351vyxeostreatmentinblastphasemyeloproliferativeneoplasmmpnbprealworldexperiencein12consecutivecases |